Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice

Journal of Clinical Investigation

Volumn 106, Issue 11, 2000, Pages 1341-1350

  Hattori, Noboru ^a   Degen, Jay L ^b   Sisson, Thomas H ^a   Liu, Hong ^b   Moore, Bethany B ^a   Pandrangi, Raj G ^a   Simon, Richard H ^a,c   Drew, Angela F ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FIBRIN; FIBRINOGEN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANEXAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GENE DELETION; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTECTION; PROTEIN DEGRADATION;

EID: 0033659495     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10531     Document Type: Article

References (49)

1. The value of edema fluid protein measurement in patients with pulmonary edema
2. Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis
3. The pathogenesis of bleomycin-induced pulmonary, fibrosis in mice
4. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
5. Treatment of bleomycin-induced pulmonary fibrosis by transfer off urokinase-type plasminogen activator genes
6. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
7. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
8. Proteolytic control of growth factor availability
9. Plasminogen deficiency, leads to impaired remodeling after a toxic injury to the liver
10. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
11. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization
12. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
13. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid
14. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Crypcococcus neoformans
15. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo
16. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation
17. Transvascular flux and tissue accrual of Evans blue: Effects of endoroxin and histamine
18. Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines
19. Ligneous conjunctivitis in plasminogen-deficient mice
20. Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice
21. Polymerization of fibrinogen in murine bleomycin-induced lung injury
22. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease
23. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition
24. Studies on the mechanism of the antifibrinolytic action of tranexamic acid
25. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator
26. The cell biology of the plasminogen system
27. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
28. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
29. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system
30. Partial reversal of established bleomycin-induced pulmonary fibrosis by rhurokinase in a rat model
31. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
32. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin
33. Cell-associated plasminogen activation: Regulation and physiological functions
34. The plasminogen activator/plasmin system
35. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
36. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
37. Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo
38. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study
39. Identification of the urokinase receptor as an adhesion receptor for vitronectin
40. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
41. Receptor-mediated internalization and degradation of urokinase is caused byits specific inhibitor PAI-1
42. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
43. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type
44. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
45. Exacerbation of antigen-induced arthritis in urokinase-deficient mice
46. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease
47. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: A prospective randomised multicentre study
48. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
49. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice